NCT00635037View on ClinicalTrials.gov

Myofascial Pain:Acupuncture Versus Trigger Point Injection Combined With Dipyrone and Cyclobenzaprine

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

November 30, 2006

Conditions
Myofascial Pain Syndromes
Interventions
DRUG

bupivacaine and acupuncture

"* trigger point injection of 0.25% bupivacaine (1 ml/point) twice a week, 10 mg/day cyclobenzaprine and 500 mg dipyrone every 8 h.~* acupuncture twice a week"

Trial Locations (1)

Unknown

Pain Setor of Federal University of Sao Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00635037 - Myofascial Pain:Acupuncture Versus Trigger Point Injection Combined With Dipyrone and Cyclobenzaprine | Biotech Hunter | Biotech Hunter